The study shows that an immunological reaction involving platelets is not uncommon in individuals receiving anti-SARS-CoV-2 vaccination, especially after ChAdOx1 and Ad26.COV2.S, and that it associates with in vivo platelet and blood clotting activation.
Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers / Fabio Almerigogna. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 1365-2141. - STAMPA. - (2022), pp. 198.257-198.266. [10.1111/bjh.18245]
Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers
Fabio Almerigogna
2022
Abstract
The study shows that an immunological reaction involving platelets is not uncommon in individuals receiving anti-SARS-CoV-2 vaccination, especially after ChAdOx1 and Ad26.COV2.S, and that it associates with in vivo platelet and blood clotting activation.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Br J Haematol - 2022 - Petito - Anti‐severe acute respiratory syndrome coronavirus‐2 adenoviral‐vector vaccines trigger.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
1.03 MB
Formato
Adobe PDF
|
1.03 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
